Better Buy: Biogen vs. Gilead Sciences
Biogen (NASDAQ: BIIB) and Gilead Sciences (NASDAQ: GILD) are both biotech royalty. In the not-so-distant past, these two top biotech stocks clobbered the broader markets in terms of their share price performance, and they did so for several years running.
However, Biogen and Gilead have both hit a rough patch over the past few years, causing their shares to lag behind the high-flying biotech industry. Which of these elite biotech companies is in the best position to get back to their winning ways? Let's take a look at how Biogen and Gilead stack up in several key areas to find out.
Image Source: Getty Images.
Source Fool.com